Overview
No overview information available.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| STI Pharma LLC | 54879-005 | ORAL | 1.25 mg in 5 mL | 7/29/2015 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| SINIFED TAB | N/A | N/A | N/A | 5/11/2012 | |
| UNI-FEDRA COMPOUND SYRUP | N/A | N/A | N/A | 6/22/1990 | |
| UNI-FEDRA TABLET | N/A | N/A | N/A | 5/2/2013 | |
| UNI-FEDRA DM SYRUP | N/A | N/A | N/A | 4/23/1998 | |
| DOCTOR COUGH SYRUP | N/A | synco (h.k.) limited | N/A | N/A | 3/11/1999 |
| DUOFED TABLETS | N/A | N/A | N/A | 3/25/2013 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| SUDAFED SINUS + PAIN RELIEF DAY & NIGHT uncoated tablet blister pack | 46869 | Medicine | A | 10/26/1993 | |
| CODRAL ORIGINAL DAY & NIGHT uncoated tablet blister pack | 275261 | Medicine | A | 5/11/2016 | |
| SUDAFED SINUS + ALLERGY & PAIN RELIEF tablet blister pack | 40335 | Medicine | A | 7/22/1992 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| COTRIFED | technilab pharma inc. | 00809144 | Liquid - Oral | 2 MG / 5 ML | 12/31/1989 |
| TEVA-COTRIDIN | teva canada limited | 02169126 | Syrup - Oral | 2 MG / 5 ML | 7/30/1996 |
| ACTIFED DM SYRUP | warner-lambert canada inc. | 02239152 | Syrup - Oral | 1.25 MG / 5 ML | N/A |
| TEVA-COTRIDIN EXPECTORANT | teva canada limited | 02053403 | Syrup - Oral | 2 MG / 5 ML | 12/31/1994 |
| COACTIFED | 00068756 | Syrup - Oral | 2 MG / 5 ML | 12/31/1963 | |
| ACTIFED DM TABLETS | warner-lambert canada inc. | 02239153 | Tablet - Oral | 2.5 MG | N/A |
| ACTIFED TABLETS | mcneil consumer healthcare division of johnson & johnson inc | 02238302 | Tablet - Oral | 2.5 MG | 12/22/1999 |
| ACTIFED PLUS CAPLETS | mcneil consumer healthcare division of johnson & johnson inc | 02239154 | Tablet - Oral | 2.5 MG | 4/14/2000 |
| COACTIFED | 00068608 | Tablet - Oral | 4 MG | 12/31/1963 | |
| ACTIFED DM TABLETS | glaxo wellcome inc. | 02049821 | Tablet - Oral | 2.5 MG / TAB | 12/31/1994 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.